Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: A retrospective pooled analysis
- Paul Emery
- , Philip J. Mease
- , Andrea Rubbert-Roth
- , Jeffrey R. Curtis
- , Ulf Mü Ller-Ladner
- , Norman B. Gaylis
- , Sarah Williams
- , Mark Reynard
- , Helen Tyrrell
Research output: Contribution to journal › Article › peer-review
46
Scopus
citations